ArticleMedicine2025
Causal association between immune cytokines and psoriasis: A two-way Mendelian randomization study.
Article in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The aim of this research was to explore the potential causal links between various immune cell profiles and the risk of psoriasis, employing a systematic two-sample Mendelian randomization (MR) analysis. The inverse variance weighted (IVW) model is the most commonly used two-sample MR analysis method for estimating the causal effect of exposure on outcomes. In addition to the IVW, we also used the weighted median method, the MR Egger method, and Steiger test as sensitivity analyses. Sensitivity analyses were performed using Cochran Q test for both IVW and MR Egger methods. The MR Egger intercept test was performed to assess horizontal multidimensionality by testing instrumental variables. All 4 immune cells associated with HLA DR (HLA DR++ monocyte %leukocyte, HLA DR on CD14+ CD16- monocyte, HLA DR on CD14+ monocyte, and HLA DR on monocyte) exhibited a significant negative correlation with psoriasis. Further analysis demonstrated that the performance of HLA DR on CD14+ CD16- monocyte and HLA DR on CD14+ monocyte was consistent and robust across multiple tests, with no significant heterogeneity or horizontal pleiotropy observed. This study corroborates the protective role of these 4 immune cells in psoriasis, with a particular focus on HLA DR on CD14+ CD16- monocytes and HLA DR on CD14+ monocytes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.